Enpp-Carbonic-anhydrase-IN-2-DataSheet-生命科學(xué)試劑-MCE_第1頁
Enpp-Carbonic-anhydrase-IN-2-DataSheet-生命科學(xué)試劑-MCE_第2頁
Enpp-Carbonic-anhydrase-IN-2-DataSheet-生命科學(xué)試劑-MCE_第3頁
全文預(yù)覽已結(jié)束

下載本文檔

版權(quán)說明:本文檔由用戶提供并上傳,收益歸屬內(nèi)容提供方,若內(nèi)容存在侵權(quán),請(qǐng)進(jìn)行舉報(bào)或認(rèn)領(lǐng)

文檔簡(jiǎn)介

Hotline:400-820-3792Inhibitors?ScreeningLibraries?Proteinswww.MedChemEEnpp/Carbonicanhydrase-IN-2Cat.No.:HY-151917分?式:C??H??FNO?S分?量:429.5作?靶點(diǎn):Apoptosis;CarbonicAnhydrase;Phosphodiesterase(PDE)作?通路:Apoptosis;MetabolicEnzyme/Protease儲(chǔ)存?式:PleasestoretheproductundertherecommendedconditionsintheCertificateofAnalysis.BIOLOGICALACTIVITY?物活性Enpp/Carbonicanhydrase-IN-2(compound1i)?種有效的Enpp和carbonicanhydrase抑制劑,對(duì)NPP1、NPP2、NPP3、CA-IX,CA-XII的IC50值分別1.13、1.07、0.74、0.33、0.68。Enpp/Carbonicanhydrase-IN-2對(duì)癌細(xì)胞具有抗增殖活性,對(duì)正常細(xì)胞具有低細(xì)胞毒性。Enpp/Carbonicanhydrase-IN-2誘導(dǎo)細(xì)胞凋亡(Apoptosis)[1]。IC50&TargetCAⅨCAXIINPP1NPP20.33μM(IC50)0.68μM(IC50)1.13μM(IC50)1.07μM(IC50)NPP30.74μM(IC50)體外研究Enpp/Carbonicanhydrase-IN-2(compound1i)(0-100μM;)inhibitssomecancercellsgrowthwithIC50sof0.58,0.58,0.63,0.42,0.20,0.72,0.41,0.76,0.94,0.28,0.49,0.59,0.83μMforK-562,COLO205,HCT-116,HCT-15,HT29,KM12,SW-620,SF-539,NCI/ADR-RES,A498,PC-3,MCF7,T-47Dcells,respectively[1].Enpp/Carbonicanhydrase-IN-2(0-2μM)showslowcytotoxicagainstnormalbreastepithelialcells(HME1)andnormalskinfibroblastcells(F180)withIC50sof>50μM[1].Enpp/Carbonicanhydrase-IN-2(0.58,1.16μM)inducesapoptosisinadose-dependentmanneratK-562cells[1].CellProliferationAssay[1]CellLine:K-562,COLO205,HCT-116,HCT-15,HT29,KM12,SW-620,SF-539,NCI/ADR-RES,A498,PC-3,MCF7,T-47Dcells1/2MasterofBioactiveMolecules—您?邊的抑制劑?師www.MedChemEConcentration:0-100μMIncubationTime:Result:InhibitedthecellgrowthwithIC50sof0.58,0.58,0.63,0.42,0.20,0.72,0.41,0.76,0.94,0.28,0.49,0.59,0.83μMforK-562,COLO205,HCT-116,HCT-15,HT29,KM12,SW-620,SF-539,NCI/ADR-RES,A498,PC-3,MCF7,T-47Dcells,respectively.ApoptosisAnalysis[1]CellLine:K-562cellsConcentration:0.58,1.16μMIncubationTime:Result:Inducedapoptosisinadose-dependentmanner.REFERENCES[1].AfnanI.Shahin,etal.Designandsynthesisofnewadamantylderivativesaspromisingantiproliferativeagents.EuropeanJournalofMedicinalChemistry,2022.McePdfHeightCaution:Producthasnotbeenfullyvalidatedformedicalapplications.Forresearchuseonly

溫馨提示

  • 1. 本站所有資源如無特殊說明,都需要本地電腦安裝OFFICE2007和PDF閱讀器。圖紙軟件為CAD,CAXA,PROE,UG,SolidWorks等.壓縮文件請(qǐng)下載最新的WinRAR軟件解壓。
  • 2. 本站的文檔不包含任何第三方提供的附件圖紙等,如果需要附件,請(qǐng)聯(lián)系上傳者。文件的所有權(quán)益歸上傳用戶所有。
  • 3. 本站RAR壓縮包中若帶圖紙,網(wǎng)頁內(nèi)容里面會(huì)有圖紙預(yù)覽,若沒有圖紙預(yù)覽就沒有圖紙。
  • 4. 未經(jīng)權(quán)益所有人同意不得將文件中的內(nèi)容挪作商業(yè)或盈利用途。
  • 5. 人人文庫(kù)網(wǎng)僅提供信息存儲(chǔ)空間,僅對(duì)用戶上傳內(nèi)容的表現(xiàn)方式做保護(hù)處理,對(duì)用戶上傳分享的文檔內(nèi)容本身不做任何修改或編輯,并不能對(duì)任何下載內(nèi)容負(fù)責(zé)。
  • 6. 下載文件中如有侵權(quán)或不適當(dāng)內(nèi)容,請(qǐng)與我們聯(lián)系,我們立即糾正。
  • 7. 本站不保證下載資源的準(zhǔn)確性、安全性和完整性, 同時(shí)也不承擔(dān)用戶因使用這些下載資源對(duì)自己和他人造成任何形式的傷害或損失。

評(píng)論

0/150

提交評(píng)論